M. Rietschel et al., EFFICACY AND SIDE-EFFECTS OF CLOZAPINE - TESTING FOR ASSOCIATION WITHALLELIC VARIATION IN THE DOPAMINE D-4 RECEPTOR GENE, Neuropsychopharmacology, 15(5), 1996, pp. 491-496
Genetic factors are supposed to play a major role not only in the etio
logy of psychiatric disorders but also in individual response to medic
ations. To test the hypothesis that interindividual differences in res
ponse to clozapine and the occurrence of side-effects might be influen
ced by variations in the dopamine D-4 receptor gene, we examined frequ
encies of four known polymorphic sites affecting protein structure in
the dopamine D-4 receptor gene in 149 patients with schizophrenia or s
chizoaffective disorder treated with clozapine. The D-4 polymorphisms
included a 13-base pair deletion, which through a frameshift leads to
a truncated nonfunctional receptor protein. There were, however, no si
gnificant differences in genotype counts between responders and non-re
sponders. Furthermore, no side-effect was found to be associated with
genetic variants of the dopamine D-4 receptor. (C) 1996 American Colle
ge of Neuropsychopharmacology